Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction

Journal of the American College of Cardiology

Volumn 36, Issue 3, 2000, Pages 739-745

  Sciagrà, Roberto ^a   Pellegri, Marco ^a   Pupi, Alberto ^a   Bolognese, Leonardo ^b   Bisi, Gianni ^c   Carnovale, Vito ^a,b,c   Santoro, Giovanni M ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CELL VIABILITY; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; FEMALE; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; NITRATES; PROGNOSIS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TISSUE SURVIVAL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0033860576     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00797-X     Document Type: Article

References (34)

1. Reversible ischemic left ventricular dysfunction: Evidence for the 'hibernating myocardium'
2. The hibernating myocardium
3. Reversibility of cardiac wall motion abnormalities predicted by positron tomography
4. 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function
5. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability
6. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction
7. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography
8. Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization
9. Prognostic value of an increase in fluorine-18-deoxyglucose uptake in patients with myocardial infarction: Comparison with stress thallium imaging
10. Value of metabolic imaging with positron emission tomography for evaluation prognosis in patients with coronary artery disease and left ventricular dysfunction
11. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization
12. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy
13. Prognostic value of tomographic rest-redistribution thallium-201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction
14. Incremental prognostic value of thallium reinjection after stress-redistribution imaging in patients with previous myocardial infarction and left ventricular dysfunction
15. Successful coronary revascularization improves prognosis in patients with previous myocardial infarction and evidence of viable myocardium at thallium-201 imaging
16. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular dysfunction
17. 99mTc-sestamibi
18. Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: Feasibility and reliability for prediction of postrevascularization outcome of asynergic territories
19. Comparison of baseline-nitrate technetium-99m-sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery
20. 99mTc-sestamibi tomography before coronary bypass graft surgery. Correlation with histopathologic and postoperative improvement in cardiac function
21. Significance of rest technetium-99m sestamibi imaging for the prediction of improvement of left ventricular dysfunction after Q-wave myocardial infarction: Importance of infarct location adjusted thresholds
22. Prognostic value of a coronary artery jeopardy score
23. Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18-fluorodeoxyglucose single-photon emission computed tomography
24. Comparison of regional and global left ventricular function by serial echocardiograms after reperfusion in acute myocardial infarction
25. Influence of complete coronary revascularization on relief of angina
26. Importance of complete revascularization in performance of the coronary bypass operation
27. Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery. A report from the Coronary Artery Surgery Study (CASS) registry
28. Management of heart failure: III. The role of revascularization in the treatment of patients with moderate or severe left ventricular dysfunction
29. Management of chronic stable angina: Medical therapy, percutaneous transluminal coronary angioplasty, and coronary artery bypass graft surgery. Lessons from randomized trials
30. Cardiac mortality and myocardial infarction in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial
31. Long-term outcome of patients with incomplete vs complete revascularization after multivessel PTCA
32. Long-term outcome of patients with depressed left ventricular function undergoing percutaneous transluminal coronary angioplasty. The NHLBI PTCA Registry
33. The degree of revascularization and outcome after multivessel coronary angioplasty
34. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advances ischemic heart disease